CHPT
ChargePoint Holdings, Inc.
CHPT has a slight edge over NIO overall, supported by stronger modeled upside.
NIO
NIO Inc.
NIO has lower modeled downside risk, despite its lower overall score.
CHPT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CHPT's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
CHPT PE Valuation
CHPT has no meaningful PE right now: it lost money over the past year.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
CHPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CHPT's losses to shrink, with revenue growing.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
CHPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.26 | +$4.19 |
| Q2 2026 | -$8.76 | +$3.04 |
| Q1 2026 | -$9.41 | +$3.39 |
| Q4 2025 | -$10.08 | +$4.32 |
| Q3 2025 | -$11.45 | +$7.95 |
| Q2 2025 | -$11.80 | +$11.40 |
| Q1 2025 | -$12.80 | +$11.60 |
| Q4 2024 | -$14.40 | +$10.20 |
CHPT has the edge over NIO on earnings, with more consistent year-over-year improvement.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
CHPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.1M | +18% |
| Q2 2026 | $101.8M | +4.3% |
| Q1 2026 | $109.3M | +7.3% |
| Q4 2025 | $105.7M | +6.1% |
| Q3 2025 | $98.6M | -9.2% |
| Q2 2025 | $97.6M | -8.8% |
| Q1 2025 | $101.9M | -12% |
| Q4 2024 | $99.6M | -9.7% |
CHPT's revenue is recovering but still below its 2023 peak: $116M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -29% | +31 points |
| Q2 2026 | -46% | +8.8 points |
| Q1 2026 | -48% | +5.5 points |
| Q4 2025 | -42% | +27 points |
| Q3 2025 | -60% | -2 points |
| Q2 2025 | -55% | +7.6 points |
| Q1 2025 | -54% | +26 points |
| Q4 2024 | -68% | +71 points |
CHPT's operating margin was −29% last quarter, up 30 points from the same quarter a year ago, near the top of its range since 2019.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over CHPT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO has the edge over CHPT on profitability, with a higher operating margin.
CHPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.2M | +$2.3M |
| Q2 2026 | -$37.7M | -$3.7M |
| Q1 2026 | -$2M | +$2.6M |
| Q4 2025 | -$23.6M | +$9.8M |
| Q3 2025 | -$7.5M | +$47.5M |
| Q2 2025 | -$34M | +$32M |
| Q1 2025 | -$4.6M | +$41.6M |
| Q4 2024 | -$33.4M | +$68.3M |
CHPT has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
CHPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.9% | +1.7M shares |
| 1 year | +13% | +3.1M shares |
| 3 years | +48% | +8.5M shares |
| 5 years | +68% | +10.6M shares |
CHPT has 26M diluted shares, up 13% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has the edge over CHPT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
CHPT Net Leverage
CHPT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CHPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.1 | Neutral |
| Stochastic | 84.4 | Overbought |
CHPT's weekly RSI is 65 (neutral) and its Stochastic is 84 (overbought).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
CHPT PE vs Consumer Cyclical Sector
CHPT has no meaningful PE right now: it lost money over the past year.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
CHPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 29% above |
| 20 week MA | $7.81 | 54% above |
| 50 week MA | $7.08 | 70% above |
| 100 week MA | $10.4 | 16% above |
| 200 week MA | $49.3 | 76% below |
CHPT has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
CHPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $196.0 | $922.0 | +370% |
| 2021 | $922.0 | $381.0 | -59% |
| 2022 | $381.0 | $171.0 | -55% |
| 2023 | $171.0 | $46.8 | -73% |
| 2024 | $46.8 | $22.8 | -51% |
| 2025 | $22.8 | $7.08 | -69% |
| 2026 YTD | $7.08 | $12.1 | +70% |
CHPT has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.